p21 Ras (HRAS) Human Knockdown Lysate

SKU LY300202

WB-validated HRAS Knockdown HeLa Cell Lysate

Product Data

• Species: Human
• Target Symbol: p21 Ras
• Expression Host: HeLa
• Lysate QC: RT-qPCR; Western Blotting (WB)
• Tag: Tag Free
• Synonyms: HRAS; HRas Proto-Oncogene, GTPase; HRAS1; V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog; Harvey Rat Sarcoma Viral Oncogene Homolog; Transforming Protein P21; GTPase HRas; P21ras; Ras Family Small GTP Binding Protein H-Ras; Harvey Rat Sarcoma Viral Oncoprotein; Transformation Gene: Oncogene HAMSV; GTP- And GDP-Binding Peptide B; Ha-Ras1 Proto-Oncoprotein; C-Has/Bas P21 Protein; P19 H-RasIDX Protein; EC 3.6.5.2; C-BAS/HAS; C-HA-RAS1; H-RASIDX; C-H-RAS; H-Ras-1; C-H-Ras; Ha-Ras; HAMSV; RASH1; CTLO
• Predicted MW: 21 kDa
• Components: 1 vial of 100 ug WT HeLa cell lysate; 1 vial of 100 ug HRAS KD HeLa cell lysate
• Note: Instruction of use: This knockdown cell lysate should be paired with wild-type HeLa cell lysate for use. For Western blotting, we recommend running wild-type and knockdown lysates on the same gel, and loading each well with equal volume and equal amount of total proteins.
• Storage: Store at -20 ℃ for two years.
• Shipping: Blue Ice
• Concentration: Lot-specific
• Buffer: IntactProtein Cell-Tissue Lysis buffer

Reference Data

• Locus ID: 3265
• UniProt ID: P01112
• Protein Families: Druggable Genome
• Protein Pathways: Acute myeloid leukemia, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Focal adhesion, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pathways in cancer, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Tight junction, VEGF signaling pathway